Restorative Dentistry Market Size, Share & Trends Analysis Report By Product (Restorative Materials, Implants, Prosthetics), By End-use (Dental Hospitals & Clinics, Dental Labs, Research & Teaching Institutes), By Region, And Segment Forecasts, 2025 - 2030
Restorative Dentistry Market Growth & Trends
The global restorative dentistry market size is expected to reach USD 34.8 billion by 2030, registering a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the restorative dentistry market is attributed to the improved quality of services offered and the availability of large patient pool. Moreover, innovation in implants & prosthetics, increasing demand for cosmetic dentistry, and growth of dental tourism is expected to fuel market growth in the forecast period.
The COVID-19 pandemic has adversely affected the dental market in 2020. According to the WHO guidelines, viral infection mainly spreads through the eyes, nose, and mouth which makes it difficult for the dentist to operate on patients during such times. Routine cleaning, orthodontic procedures, preventive therapies, and oral examinations that do not involve pain management were postponed during the COVID-19 pandemic thus negatively impacting the restorative dentistry market.
Technological advancement such as guided tissue regeneration with CAM/CAD software solutions, computer-aided implant dentistry, and digital radiography has improved the accuracy of restorations. The new equipment and composite materials have attracted the patient for treatment and resulted in better health outcomes and higher satisfaction along with timeliness of dental treatment. Thus, advanced technology is anticipated to boost the restorative dentistry market.
The lack of reimbursement may affect the market. The reimbursement policies for the dental structure including restorative dentistry is limited. Patients must bear out-of-pocket expenditure that is included with dental procedures thus, patient mainly ignores and delay their dental treatments due to huge expenses. Dental procedures such as composite bonding, implants, and cosmetic contouring require highly skilled lab technicians and professionals. Thus, dental procedures are very costly in many countries. This factor may hamper the market growth.
Restorative Dentistry Market Report Highlights
- Restorative material accounted for the highest market share of around 43.9% in 2024. The rapid growth of the segment is attributed to the increasing prominence of aesthetics, which results in cosmetic dentistry procedures.
- Dental hospitals and clinics accounted for the highest market share of around 56.2% in 2024. The market's growth is anticipated due to the increasing number of hospitals and dental clinics in regions such as Asia Pacific and Europe.
- Asia Pacific restorative dentistry market growth is driven by rising dental tourism and increased awareness of oral health. Countries such as India, South Korea, and Thailand have emerged as popular destinations for dental procedures due to their competitive pricing and high-quality care.
- Chapter 1. Methodology And Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Product Segment
- 1.2. Regional Scope
- 1.3. Estimates And Forecast Timeline
- 1.4. Objectives
- 1.4.1. Objective - 1
- 1.4.2. Objective – 2
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR’s Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information Or Data Analysis
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.10. List of Primary Sources
- 1.11. List of Abbreviations
- Chapter 2. Cardiac Rhythm Management Devices Market: Executive Summary
- 2.1. Market Snapshot
- 2.2. Product Snapshots
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Cardiac Rhythm Management Devices Market Variables, Trends, & Scope
- 3.1. Market Segmentation And Scope
- 3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
- 3.3. Market Dynamics
- 3.4. Market Drivers Analysis
- 3.4.1. Growing prevalence of cardiovascular disease
- 3.4.2. Increasing preference for minimally invasive procedures
- 3.5. Market Restraint Analysis
- 3.5.1. High cost associated with the devices
- 3.6. Cardiac Rhythm Management Devices Market Analysis Tools
- 3.6.1. Industry Analysis – Porter’s
- 3.6.1.1. Supplier Power
- 3.6.1.2. Buyer Power
- 3.6.1.3. Substitution Threat
- 3.6.1.4. Threat Of New Entrant
- 3.6.1.5. Competitive Rivalry
- 3.6.2. PESTLE Analysis
- 3.6.2.1. Political Landscape
- 3.6.2.2. Technological Landscape
- 3.6.2.3. Economic Landscape
- 3.6.3. Pricing Analysis
- Chapter 4. Cardiac Rhythm Management Devices: Product Estimates & Trend Analysis
- 4.1. Product Market Share, 2024 & 2030
- 4.2. Segment Dashboard
- 4.3. Global Cardiac Rhythm Management Devices Market By Product Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 To 2030 For the Following
- 4.4.1. Pacemakers
- 4.4.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 4.4.1.1.1. Implantable
- 4.4.1.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 4.4.1.1.2. External
- 4.4.1.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 4.4.2. Defibrillators
- 4.4.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 4.4.2.1.1. Implantable Cardioverter Defibrillators (ICD)
- 4.4.2.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 4.4.2.1.1.1.1. S-ICD
- 4.4.2.1.1.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 4.4.2.1.1.1.2. T-ICD
- 4.4.2.1.1.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 4.4.2.1.2. External Defibrillator
- 4.4.2.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 4.4.2.1.2.1.1. Manual External Defibrillator
- 4.4.2.1.2.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 4.4.2.1.2.1.2. Automatic External Defibrillator
- 4.4.2.1.2.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 4.4.2.1.2.1.3. Wearable Cardioverter Defibrillator
- 4.4.2.1.2.1.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 4.4.3. Cardiac Resynchronization Therapy (CRT)
- 4.4.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 4.4.3.1.1. CRT-Defibrillator
- 4.4.3.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 4.4.3.1.2. CRT-Pacemakers
- 4.4.3.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- Chapter 5. Regional Business Analysis
- 5.1. Regional Market Share Analysis, 2024 & 2030
- 5.2. Regional Market Dashboard
- 5.3. Global Regional Market Snapshot
- 5.4. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
- 5.5. North America
- 5.5.1. U.S.
- 5.5.1.1. Key Country Dynamics
- 5.5.1.2. Competitive Scenario
- 5.5.1.3. Regulatory Framework
- 5.5.1.4. U.S. Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.5.2. Canada
- 5.5.2.1. Key Country Dynamics
- 5.5.2.2. Competitive Scenario
- 5.5.2.3. Regulatory Framework
- 5.5.2.4. Canada Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.5.3. Mexico
- 5.5.3.1. Key Country Dynamics
- 5.5.3.2. Competitive Scenario
- 5.5.3.3. Regulatory Framework
- 5.5.3.4. Canada Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.6. Europe
- 5.6.1. UK
- 5.6.1.1. Key Country Dynamics
- 5.6.1.2. Competitive Scenario
- 5.6.1.3. Regulatory Framework
- 5.6.1.4. UK Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.6.2. Germany
- 5.6.2.1. Key Country Dynamics
- 5.6.2.2. Competitive Scenario
- 5.6.2.3. Regulatory Framework
- 5.6.2.4. Germany Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.6.3. Spain
- 5.6.3.1. Key Country Dynamics
- 5.6.3.2. Competitive Scenario
- 5.6.3.3. Regulatory Framework
- 5.6.3.4. Spain Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.6.4. France
- 5.6.4.1. Key Country Dynamics
- 5.6.4.2. Competitive Scenario
- 5.6.4.3. Regulatory Framework
- 5.6.4.4. France Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.6.5. Italy
- 5.6.5.1. Key Country Dynamics
- 5.6.5.2. Competitive Scenario
- 5.6.5.3. Regulatory Framework
- 5.6.5.4. Italy Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.6.6. Denmark
- 5.6.6.1. Key Country Dynamics
- 5.6.6.2. Competitive Scenario
- 5.6.6.3. Regulatory Framework
- 5.6.6.4. Denmark Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.6.7. Sweden
- 5.6.7.1. Key Country Dynamics
- 5.6.7.2. Competitive Scenario
- 5.6.7.3. Regulatory Framework
- 5.6.7.4. Sweden Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.6.8. Norway
- 5.6.8.1. Key Country Dynamics
- 5.6.8.2. Competitive Scenario
- 5.6.8.3. Regulatory Framework
- 5.6.8.4. Norway Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.7. Asia Pacific
- 5.7.1. Japan
- 5.7.1.1. Key Country Dynamics
- 5.7.1.2. Competitive Scenario
- 5.7.1.3. Regulatory Framework
- 5.7.1.4. Japan Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.7.2. China
- 5.7.2.1. Key Country Dynamics
- 5.7.2.2. Competitive Scenario
- 5.7.2.3. Regulatory Framework
- 5.7.2.4. China Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.7.3. India
- 5.7.3.1. Key Country Dynamics
- 5.7.3.2. Competitive Scenario
- 5.7.3.3. Regulatory Framework
- 5.7.3.4. India Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.7.4. South Korea
- 5.7.4.1. Key Country Dynamics
- 5.7.4.2. Competitive Scenario
- 5.7.4.3. Regulatory Framework
- 5.7.4.4. South Korea Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.7.5. Thailand
- 5.7.5.1. Key Country Dynamics
- 5.7.5.2. Competitive Scenario
- 5.7.5.3. Regulatory Framework
- 5.7.5.4. Thailand Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.7.6. Australia
- 5.7.6.1. Key Country Dynamics
- 5.7.6.2. Competitive Scenario
- 5.7.6.3. Regulatory Framework
- 5.7.6.4. Australia Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.8. Latin America
- 5.8.1. Brazil
- 5.8.1.1. Key Country Dynamics
- 5.8.1.2. Competitive Scenario
- 5.8.1.3. Regulatory Framework
- 5.8.1.4. Brazil Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.8.2. Argentina
- 5.8.2.1. Key Country Dynamics
- 5.8.2.2. Competitive Scenario
- 5.8.2.3. Regulatory Framework
- 5.8.2.4. Argentina Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.9. MEA
- 5.9.1. MEA Cardiac Rhythm Management Devices Market, 2018 - 2030 (USD Million)
- 5.9.2. South Africa
- 5.9.2.1. Key Country Dynamics
- 5.9.2.2. Competitive Scenario
- 5.9.2.3. Regulatory Framework
- 5.9.2.4. South Africa Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.9.3. Saudi Arabia
- 5.9.3.1. Key Country Dynamics
- 5.9.3.2. Competitive Scenario
- 5.9.3.3. Regulatory Framework
- 5.9.3.4. Saudi Arabia Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.9.4. UAE
- 5.9.4.1. Key Country Dynamics
- 5.9.4.2. Competitive Scenario
- 5.9.4.3. Regulatory Framework
- 5.9.4.4. UAE Market Estimates and Forecasts 2018 To 2030 (USD Million)
- 5.9.5. Kuwait
- 5.9.5.1. Key Country Dynamics
- 5.9.5.2. Competitive Scenario
- 5.9.5.3. Regulatory Framework
- 5.9.5.4. Kuwait Market Estimates and Forecasts 2018 To 2030 (USD Million)
- Chapter 6. Competitive Landscape
- 6.1. Recent Developments & Impact Analysis, By Key Market Participants
- 6.2. Company /Competition Categorization
- 6.3. Vendor Landscape
- 6.3.1. List of Key Distributors And Channel Partners
- 6.3.2. Key Customers
- 6.3.3. Key Company Market Share Analysis, 2023
- 6.3.4. Physio-Control, Inc.
- 6.3.4.1. Overview
- 6.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.3.4.3. Product Benchmarking
- 6.3.4.4. Strategic Initiatives
- 6.3.5. Medtronic, plc
- 6.3.5.1. Overview
- 6.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.3.5.3. Product Benchmarking
- 6.3.5.4. Strategic Initiatives
- 6.3.6. ABBOTT
- 6.3.6.1. Overview
- 6.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.3.6.3. Product Benchmarking
- 6.3.6.4. Strategic Initiatives
- 6.3.7. Boston Scientific Corporation
- 6.3.7.1. Overview
- 6.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.3.7.3. Product Benchmarking
- 6.3.7.4. Strategic Initiatives
- 6.3.8. Schiller
- 6.3.8.1. Overview
- 6.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.3.8.3. Product Benchmarking
- 6.3.8.4. Strategic Initiatives
- 6.3.9. Koninklijke Philips N.V
- 6.3.9.1. Overview
- 6.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.3.9.3. Product Benchmarking
- 6.3.9.4. Strategic Initiatives
- 6.3.10. Biotronik
- 6.3.10.1. Overview
- 6.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.3.10.3. Product Benchmarking
- 6.3.10.4. Strategic Initiatives
- 6.3.11. Progetti Srl
- 6.3.11.1. Overview
- 6.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.3.11.3. Product Benchmarking
- 6.3.11.4. Strategic Initiatives
- 6.3.12. Zoll Medical Corporation
- 6.3.12.1. Overview
- 6.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.3.12.3. Product Benchmarking
- 6.3.12.4. Strategic Initiatives
- 6.3.13. LivaNova Plc
- 6.3.13.1. Overview
- 6.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.3.13.3. Product Benchmarking
- 6.3.13.4. Strategic Initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook